Boyd, S.M.; Rhinehardt, K.L.; Ewunkem, A.J.; Harrison, S.H.; Thomas, M.D.; Graves, J.L., Jr.
Experimental Evolution of Copper Resistance in Escherichia coli Produces Evolutionary Trade-Offs in the Antibiotics Chloramphenicol, Bacitracin, and Sulfonamide. Antibiotics 2022, 11, 711.
https://doi.org/10.3390/antibiotics11060711
AMA Style
Boyd SM, Rhinehardt KL, Ewunkem AJ, Harrison SH, Thomas MD, Graves JL Jr.
Experimental Evolution of Copper Resistance in Escherichia coli Produces Evolutionary Trade-Offs in the Antibiotics Chloramphenicol, Bacitracin, and Sulfonamide. Antibiotics. 2022; 11(6):711.
https://doi.org/10.3390/antibiotics11060711
Chicago/Turabian Style
Boyd, Sada M., Kristen L. Rhinehardt, Akamu J. Ewunkem, Scott H. Harrison, Misty D. Thomas, and Joseph L. Graves, Jr.
2022. "Experimental Evolution of Copper Resistance in Escherichia coli Produces Evolutionary Trade-Offs in the Antibiotics Chloramphenicol, Bacitracin, and Sulfonamide" Antibiotics 11, no. 6: 711.
https://doi.org/10.3390/antibiotics11060711
APA Style
Boyd, S. M., Rhinehardt, K. L., Ewunkem, A. J., Harrison, S. H., Thomas, M. D., & Graves, J. L., Jr.
(2022). Experimental Evolution of Copper Resistance in Escherichia coli Produces Evolutionary Trade-Offs in the Antibiotics Chloramphenicol, Bacitracin, and Sulfonamide. Antibiotics, 11(6), 711.
https://doi.org/10.3390/antibiotics11060711